A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Autio, K. A.; Garcia, J. A.; Alva, A. S.; Hart, L. L.; Milowsky, M. I.; Posadas, E. M.; Ryan, C. J.; Summa, J. M.; Youssoufian, H.; Scher, H. I.; Dreicer, R.
Abstract Title: A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 2016 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 2 Suppl.
Meeting Dates: 2016 Jan 7-9
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-01-10
Language: English
ACCESSION: WOS:000378109100233
PROVIDER: wos
DOI: 10.1200/JCO.2016.34.2_suppl.233
Notes: Meeting Abstract: 233 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio
  2. Howard Scher
    1130 Scher